DK160986C - Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse - Google Patents

Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse

Info

Publication number
DK160986C
DK160986C DK175585A DK175585A DK160986C DK 160986 C DK160986 C DK 160986C DK 175585 A DK175585 A DK 175585A DK 175585 A DK175585 A DK 175585A DK 160986 C DK160986 C DK 160986C
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preparations containing
complexes
fresh
fresh complexes
Prior art date
Application number
DK175585A
Other languages
English (en)
Other versions
DK175585A (da
DK175585D0 (da
DK160986B (da
Inventor
Brian Albert Callingham
Robert Charles Hider
George Kontoghiorghes
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK175585D0 publication Critical patent/DK175585D0/da
Publication of DK175585A publication Critical patent/DK175585A/da
Publication of DK160986B publication Critical patent/DK160986B/da
Application granted granted Critical
Publication of DK160986C publication Critical patent/DK160986C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62Three oxygen atoms, e.g. ascorbic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Conveying Record Carriers (AREA)
DK175585A 1984-04-19 1985-04-18 Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse DK160986C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848410289A GB8410289D0 (en) 1984-04-19 1984-04-19 Pharmaceutical compositions
GB8410289 1984-04-19

Publications (4)

Publication Number Publication Date
DK175585D0 DK175585D0 (da) 1985-04-18
DK175585A DK175585A (da) 1985-10-20
DK160986B DK160986B (da) 1991-05-13
DK160986C true DK160986C (da) 1991-11-11

Family

ID=10559910

Family Applications (1)

Application Number Title Priority Date Filing Date
DK175585A DK160986C (da) 1984-04-19 1985-04-18 Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse

Country Status (15)

Country Link
EP (1) EP0159194B1 (da)
JP (1) JPH0794467B2 (da)
AU (1) AU582153B2 (da)
CA (1) CA1286844C (da)
CY (1) CY1575A (da)
DE (1) DE3579730D1 (da)
DK (1) DK160986C (da)
GB (2) GB8410289D0 (da)
HK (1) HK8091A (da)
IE (1) IE58667B1 (da)
IL (1) IL74949A (da)
NZ (1) NZ211788A (da)
PH (1) PH25348A (da)
SG (1) SG92490G (da)
ZA (1) ZA852830B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US4822786A (en) * 1986-07-01 1989-04-18 Kaken Pharmaceutical Co., Ltd. Cephalosporin compounds, and antibacterial agents
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
EP0325559B1 (de) * 1988-01-20 1993-12-15 Ciba-Geigy Ag Verfahren zur Herstellung von Komplexverbindungen
JPH03101676A (ja) * 1989-09-14 1991-04-26 Sansho Seiyaku Co Ltd 2―エトキシメチル―5―ヒドロキシ―γ―ピロン及び同化合物を有効成分とするメラニン生成抑制外用剤
AU7346091A (en) * 1990-03-02 1991-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparations for mr diagnosis
EP0833627B1 (en) * 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
CA2421410C (en) 2000-09-19 2009-11-10 Vitra Pharmaceuticals Limited Iron compositions
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
ES2660202T3 (es) 2010-03-23 2018-03-21 Vifor (International) Ag Compuestos del complejo Fe (iii) para el tratamiento y la profilaxis de los síntomas de deficiencia de hierro y las anemias ferropénicas
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
PH12013501968A1 (en) 2011-03-29 2013-12-16 Vifor Int Ag Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
ES2548407T3 (es) 2011-05-31 2015-10-16 Vifor (International) Ag Compuestos de complejos de 2,4-dioxo-1-carbonilo de Fe(III) para su uso en el tratamiento y la profilaxis de estados de deficiencia de hierro y anemias por deficiencia de hierro
ES2658818T3 (es) 2012-12-21 2018-03-12 Vifor (International) Ag Compuestos del complejo FE(III) para el tratamiento y la profilaxis de síntomas asociados a deficiencia de hierro y de anemias ferropénicas
WO2017167970A1 (en) * 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ferrous hydroxides
CN109071481B (zh) * 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由元素铁产生麦芽酚铁组合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
DE3365971D1 (en) * 1982-03-24 1986-10-16 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0159194A2 (en) 1985-10-23
GB2157686A (en) 1985-10-30
NZ211788A (en) 1988-06-30
DK175585A (da) 1985-10-20
PH25348A (en) 1991-05-13
CA1286844C (en) 1991-07-23
AU582153B2 (en) 1989-03-16
JPH0794467B2 (ja) 1995-10-11
DE3579730D1 (de) 1990-10-25
GB8410289D0 (en) 1984-05-31
JPS60248696A (ja) 1985-12-09
AU4141385A (en) 1985-10-24
GB8509813D0 (en) 1985-05-22
CY1575A (en) 1991-12-20
EP0159194B1 (en) 1990-09-19
ZA852830B (en) 1986-12-30
GB2157686B (en) 1987-12-16
DK175585D0 (da) 1985-04-18
HK8091A (en) 1991-02-01
EP0159194A3 (en) 1986-03-12
DK160986B (da) 1991-05-13
IL74949A (en) 1988-05-31
IE58667B1 (en) 1993-11-03
IE850992L (en) 1985-10-19
SG92490G (en) 1991-02-14

Similar Documents

Publication Publication Date Title
DK288184D0 (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK164868C (da) Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK359986D0 (da) Phenylethere, fremgangsmaader til fremstilling samt farmaceutiske midler indeholdende disse
FI860096L (fi) Haorfaergmedels-preparat.
DK231687D0 (da) Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser
DK160986C (da) Ferrikomplekser, deres anvendelse samt farmaceutiske praeparater indeholdende disse
DK85087A (da) Substituerede thienoimidazol-derivater, deres fremstilling, praeparater, indeholdende disse, samt anvendelse deraf
DK409784D0 (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK621486A (da) 1-benzensulfonyl-2-oxo-5-alkoxypyrrolidinderivater samt deres fremstilling, anvendelse og praeparater med indhold deraf
DK116989A (da) Polypeptider samt farmaceutiske praeparater indeholdende disse forbindelser
DK163057C (da) Isoindsolinyl-alkyl-piperaziner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK66086A (da) Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
FI861193L (fi) Stabilt gammainterferonpreparat.
DK143188D0 (da) Farmaceutiske praeparater indeholdende pyranoquinolinforbindelser samt deres anvendelse
DK533087A (da) Anthracyklinglykosider, deres fremstilling, mellemprodukter deraf samt praeparater indeholdende disse og deres anvendelse
DK162984C (da) 1-(2-ar-2-halogen-2-ethenyl)-1h-azoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK528285D0 (da) Peptider samt praeparater indeholdende disse
DK21785D0 (da) Dihydropyridinforbindelser og farmaceutiske praeparater indeholdende disse
DK307085D0 (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK191086D0 (da) Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK165885D0 (da) Peptider, fremgangsmaade til fremstilling deraf, samt farmaceutiske praeparater, indeholdende disse peptider
NO864034D0 (no) Fungicide preparater.
DK135789A (da) 19-thiosubstituerede delta4-androstenderivater samt farmaceutisk praeparat indeholdende disse

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK